The Universe of ALS Genetic Mutations: Understanding the Genes Behind the Disease

The universe of ALS genetic mutations is far more complex than scientists once believed. Over the past two decades, researchers have discovered that dozens of different gene mutations can contribute to ALS, helping explain why the disease appears differently from person to person. Understanding these genetic mutations has become one of the most important areas of ALS research because it reveals the biological mechanisms that drive motor neuron degeneration. One of the most significant discoveries was the mutation in the C9orf72 gene, which is now recognized as the most common known genetic cause of ALS. This mutation can lead to abnormal protein buildup and is also strongly linked to Frontotemporal Dementia, highlighting the biological connection between the two conditions. Another major gene involved in ALS is the SOD1 gene, one of the first genetic mutations discovered in ALS research. Mutations in this gene cause the SOD1 protein to become toxic to motor neurons. This discovery eventually led to the development of Qalsody, the first gene-targeting therapy for ALS. Researchers have also identified additional ALS-related genes, including the TARDBP gene and the FUS gene, both of which affect how cells manage RNA and protein processing. Disruptions in these systems can cause harmful protein aggregation inside neurons, a hallmark of ALS pathology. Today, scientists believe more than 30 genes may be linked to ALS, and new mutations continue to be discovered. Mapping this expanding genetic universe helps researchers design targeted therapies, improve genetic testing, and better understand disease progression. As genetic research advances, the growing knowledge of ALS mutations is transforming the field—from a single disease concept into a complex network of related biological pathways that may eventually lead to more personalized and effective treatments.